litlas
Log inCreate account

Charles A. Gersbach

Active 2004–2025

87
Papers
21,962
Citations
65
h-index
81
i10-index

Citations

Citations per year for Charles A. Gersbach1983: 4 citations1993: 1 citations1999: 3 citations2003: 1 citations2004: 1 citations2005: 6 citations2006: 15 citations2007: 4 citations2008: 10 citations2009: 11 citations2010: 15 citations2011: 7 citations2012: 18 citations2013: 107 citations2014: 223 citations2015: 307 citations2016: 435 citations2017: 421 citations2018: 408 citations2019: 1,067 citations2020: 1,184 citations2021: 1,154 citations2022: 1,005 citations2023: 762 citations2024: 1,093 citations2025: 596 citations2026: 11 citations1984–1992: no citations, so these years are not shown1994–1998: no citations, so these years are not shown2000–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,850 citing papers, 31% of this breakdownChina: 1,428 citing papers, 15.5% of this breakdownUnited Kingdom: 490 citing papers, 5.3% of this breakdownGermany: 480 citing papers, 5.2% of this breakdownIndia: 320 citing papers, 3.5% of this breakdownJapan: 255 citing papers, 2.8% of this breakdownCanada: 225 citing papers, 2.5% of this breakdownFrance: 213 citing papers, 2.3% of this breakdownAustralia: 212 citing papers, 2.3% of this breakdownSouth Korea: 212 citing papers, 2.3% of this breakdownItaly: 206 citing papers, 2.2% of this breakdownNetherlands: 198 citing papers, 2.2% of this breakdown
0%31%Other 22.9%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology79.1%
  • Medicine11.1%
  • Neuroscience2.5%
  • Agricultural and Biological Sciences2.4%
  • Engineering1.5%
  • Immunology and Microbiology1.4%
  • Other2%

Topics

  • CRISPR and Genetic Engineering19.3%
  • RNA Interference and Gene Delivery4.1%
  • Advanced biosensing and bioanalysis techniques3.8%
  • Virus-based gene therapy research3.8%
  • RNA and protein synthesis mechanisms3.7%
  • Pluripotent Stem Cells Research2.9%
  • Other62.4%

Coauthors

All papers

Open in search
  1. The next generation of CRISPR–Cas technologies and applications

    Authors: Adrian Pickar‐Oliver, Charles A. Gersbach - Nature Reviews Molecular Cell Biology 2019 cited by 1,493

  2. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

    Authors: Thomas Gaj, Charles A. Gersbach, Carlos F. Barbas - Trends in biotechnology 2013 cited by 3,774

  3. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers

    Authors: Isaac B. Hilton, Anthony D’Ippolito, Christopher M. Vockley, Pratiksha I. Thakore, Gregory E. Crawford, Timothy E. Reddy, Charles A. Gersbach - Nature Biotechnology 2015 cited by 1,876

  4. RNA-guided gene activation by CRISPR-Cas9–based transcription factors

    Authors: Pablo Pérez‐Piñera, D. Dewran Koçak, Christopher M. Vockley, Andrew F. Adler, Ami M. Kabadi, Lauren R. Polstein, Pratiksha I. Thakore, Katherine A. Glass, David G. Ousterout, Kam W. Leong, Farshid Guilak, Gregory E. Crawford, Timothy E. Reddy, Charles A. Gersbach - Nature Methods 2013 cited by 1,349

  5. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

    Authors: Pratiksha I. Thakore, Anthony D’Ippolito, Lingyun Song, Alexias Safi, Nishkala K. Shivakumar, Ami M. Kabadi, Timothy E. Reddy, Gregory E. Crawford, Charles A. Gersbach - Nature Methods 2015 cited by 1,045

  6. The once and future gene therapy

    Authors: Karen Bulaklak, Charles A. Gersbach - Nature Communications 2020 cited by 322

  7. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy

    Authors: Christopher E. Nelson, Chady H. Hakim, David G. Ousterout, Pratiksha I. Thakore, Eirik A. Moreb, Ruth M. Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F. Ann Ran, Winston X. Yan, Aravind Asokan, Feng Zhang, Dongsheng Duan, Charles A. Gersbach - Science 2015 cited by 1,152

  8. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy

    Authors: Christopher E. Nelson, Yaoying Wu, Matthew Gemberling, Matthew L. Oliver, Matthew A. Waller, Joel D. Bohning, Jacqueline N. Robinson-Hamm, Karen Bulaklak, Ruth M. Castellanos Rivera, Joel H. Collier, Aravind Asokan, Charles A. Gersbach - Nature Medicine 2019 cited by 429

  9. Increasing the specificity of CRISPR systems with engineered RNA secondary structures

    Authors: D. Dewran Koçak, Eric A. Josephs, Vidit Bhandarkar, Shaunak Adkar, Jennifer B. Kwon, Charles A. Gersbach - Nature Biotechnology 2019 cited by 361

  10. Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models

    Authors: Chady H. Hakim, Sandeep Kumar, Dennis O. Pérez‐López, Nalinda B. Wasala, Dong Zhang, Yongping Yue, James Teixeira, Xiufang Pan, Keqing Zhang, Emily D. Million, Christopher E. Nelson, Samantha Metzger, Jin-Young Han, Jacqueline A. Louderman, Florian Schmidt, Feng Feng, Dirk Grimm, B. F. Smith, Gang Yao, N. Nora Yang, Charles A. Gersbach, Shi‐Jie Chen, Roland W. Herzog, Dongsheng Duan - Nature Communications 2021 cited by 170

  11. Editing the epigenome: technologies for programmable transcription and epigenetic modulation

    Authors: Pratiksha I. Thakore, Joshua B. Black, Isaac B. Hilton, Charles A. Gersbach - Nature Methods 2016 cited by 448

  12. Genome-editing Technologies for Gene and Cell Therapy

    Authors: Morgan L. Maeder, Charles A. Gersbach - Molecular Therapy 2016 cited by 718

  13. A light-inducible CRISPR-Cas9 system for control of endogenous gene activation

    Authors: Lauren R. Polstein, Charles A. Gersbach - Nature Chemical Biology 2015 cited by 651

  14. CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome

    Authors: Tyler S. Klann, Joshua B. Black, Malathi Chellappan, Alexias Safi, Lingyun Song, Isaac B. Hilton, Gregory E. Crawford, Timothy E. Reddy, Charles A. Gersbach - Nature Biotechnology 2017 cited by 470

  15. Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens

    Authors: Sean R. McCutcheon, Adam M. Swartz, Michael C. Brown, Alejandro Barrera, Christian McRoberts Amador, Keith Siklenka, Lucas Humayun, Maria A. ter Weele, James Isaacs, Timothy E. Reddy, Andrew S. Allen, Smita K. Nair, Scott J. Antonia, Charles A. Gersbach - Nature Genetics 2023 cited by 78

  16. Transgenic mice for in vivo epigenome editing with CRISPR-based systems

    Authors: Matthew Gemberling, Keith Siklenka, Erica Rodriguez, Katherine R. Tonn Eisinger, Alejandro Barrera, Fang Liu, Ariel Kantor, Liqing Li, Valentina Cigliola, Mariah F. Hazlett, Courtney Williams, Luke C. Bartelt, Victoria J. Madigan, Josephine C. Bodle, Heather Daniels, Douglas Rouse, Isaac B. Hilton, Aravind Asokan, Maria Ciofani, Kenneth D. Poss, Timothy E. Reddy, Anne E. West, Charles A. Gersbach - Nature Methods 2021 cited by 138

  17. Epigenome editing technologies for discovery and medicine

    Authors: Sean R. McCutcheon, Dahlia Rohm, Nahid Iglesias, Charles A. Gersbach - Nature Biotechnology 2024 cited by 95

  18. Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing

    Authors: Trevor Gonzalez, Katherine E. Simon, Leo O. Blondel, Marco M. Fanous, Angela L. Roger, Maribel Santiago Maysonet, Garth Devlin, Timothy J. Smith, Daniel K. Oh, L. Patrick Havlik, Ruth M. Castellanos Rivera, Jorge A. Piedrahita, Mai K. ElMallah, Charles A. Gersbach, Aravind Asokan - Nature Communications 2022 cited by 81

  19. Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector

    Authors: Ami M. Kabadi, David G. Ousterout, Isaac B. Hilton, Charles A. Gersbach - Nucleic Acids Research 2014 cited by 388

  20. RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors

    Authors: Pratiksha I. Thakore, Jennifer B. Kwon, Christopher E. Nelson, Douglas Rouse, Matthew Gemberling, Matthew L. Oliver, Charles A. Gersbach - Nature Communications 2018 cited by 174

  21. Enhancer Histone Acetylation Modulates Transcriptional Bursting Dynamics of Neuronal Activity-Inducible Genes

    Authors: Liang-Fu Chen, Yen Ting Lin, David A. Gallegos, Mariah F. Hazlett, Mariana Gómez-Schiavon, Marty G. Yang, Breanna Kalmeta, Allen S. Zhou, Liad Holtzman, Charles A. Gersbach, Jörg Grandl, Nicolas E. Buchler, Anne E. West - Cell Reports 2019 cited by 177

  22. Multicenter integrated analysis of noncoding CRISPRi screens

    Authors: David Yao, Josh Tycko, Jin Woo Oh, Lexi R. Bounds, Sager J. Gosai, Lazaros Lataniotis, Ava Mackay-Smith, Benjamin R. Doughty, Idan Gabdank, Henri Schmidt, Tania Guerrero-Altamirano, Keith Siklenka, Katherine Guo, Alexander D. White, Ingrid Youngworth, Kalina Andreeva, Xingjie Ren, Alejandro Barrera, Yunhai Luo, Galip Gürkan Yardımcı, Ryan Tewhey, Anshul Kundaje, William J. Greenleaf, Pardis C. Sabeti, Christina S. Leslie, Yuri Pritykin, Jill E. Moore, M Beer, Charles A. Gersbach, Timothy E. Reddy, Yin Shen, J Engreitz, Michael C. Bassik, Steven K. Reilly - Nature Methods 2024 cited by 50

  23. Full-length dystrophin restoration via targeted exon integration by AAV-CRISPR in a humanized mouse model of Duchenne muscular dystrophy

    Authors: Adrian Pickar‐Oliver, Veronica Gough, Joel D. Bohning, Siyan Liu, Jacqueline N. Robinson-Hamm, Heather Daniels, William H. Majoros, Garth Devlin, Aravind Asokan, Charles A. Gersbach - Molecular Therapy 2021 cited by 67

  24. Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart

    Authors: Jacquelyn M. Walejko, Bridgette A. Christopher, Scott B. Crown, Guofang Zhang, Adrian Pickar‐Oliver, Takeshi Yoneshiro, Matthew W. Foster, Stephani C. Page, Stephan van Vliet, Olga Ilkayeva, Michael J. Muehlbauer, Matthew W. Carson, Joseph T. Brozinick, Craig D. Hammond, Ruth E. Gimeno, M. Arthur Moseley, Shingo Kajimura, Charles A. Gersbach, Christopher B. Newgard, Phillip J. White, Robert W. McGarrah - Nature Communications 2021 cited by 97